| ■ 영문 제목 : Global In-Vitro Cancer Diagnostic Reagent Kit Market Growth 2021-2026 | |
 | ■ 상품코드 : LPI-2201K00305 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 110 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료, 제약 |
| Single User (1명 열람용) | USD3,660 ⇒환산￦5,124,000 | 견적의뢰/주문/질문 |
| Multi User (5명 열람용) | USD5,490 ⇒환산￦7,686,000 | 견적의뢰/주문/질문 |
| Corporate User (동일기업내 공유가능) | USD7,320 ⇒환산￦10,248,000 | 견적의뢰/구입/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| 본 조사보고서는 체외 암 진단 시약 키트의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (혈액 검사, 대변 검사, 소변 검사)와 용도별 시장규모 (폐암, 결장 직장암, 전립선암, 유방암, 난소암, 기타) 데이터도 수록되어 있습니다. - 조사 범위 - 경영자용 요약 - 기업별 체외 암 진단 시약 키트 시장 점유율 - 지역별 체외 암 진단 시약 키트 시장규모 - 주요지역의 종류별 시장규모 (혈액 검사, 대변 검사, 소변 검사) - 주요지역의 용도별 시장규모 (폐암, 결장 직장암, 전립선암, 유방암, 난소암, 기타) - 미주의 체외 암 진단 시약 키트 시장규모 (미국, 캐나다, 멕시코, 브라질 등) - 아시아의 체외 암 진단 시약 키트 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등) - 유럽의 체외 암 진단 시약 키트 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등) - 중동/아프리카의 체외 암 진단 시약 키트 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등) - 시장의 성장요인, 과제, 동향 - 마케팅, 유통업자, 고객리스트 - 세계의 체외 암 진단 시약 키트 시장예측 (2021년-2026년) - 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) Abbott, Beckman Coulter, Siemens Healthcare, Eiken Chemical, Hitachi Chemical Diagnostics Systems, Clinical Genomics Pty Ltd (Quest Diagnostics), Sysmex, QIAGEN, R-Biopharm, Immunostics, OPKO, Epigenomics AG, bioMeriux, Roche, MDx Health, Randox Laboratories - 조사의 결과/결론 |
According to this latest study, the 2021 growth of In-Vitro Cancer Diagnostic Reagent Kit will have significant change from previous year. By the most conservative estimates of global In-Vitro Cancer Diagnostic Reagent Kit market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the In-Vitro Cancer Diagnostic Reagent Kit market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of In-Vitro Cancer Diagnostic Reagent Kit market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Blood Test
Stool Test
Urine Test
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Lung Cancer
Colorectal Cancer
Prostate Cancer
Breast Cancer
Ovarian Cancer
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Abbott
Beckman Coulter
Siemens Healthcare
Eiken Chemical
Hitachi Chemical Diagnostics Systems
Clinical Genomics Pty Ltd (Quest Diagnostics)
Sysmex
QIAGEN
R-Biopharm
Immunostics
OPKO
Epigenomics AG
bioMeriux
Roche
MDx Health
Randox Laboratories
1 Scope of the Report 2 Executive Summary 3 Global In-Vitro Cancer Diagnostic Reagent Kit by Company 4 In-Vitro Cancer Diagnostic Reagent Kit by Region 5 Americas 6 APAC 7 Europe 8 Middle East & Africa 9 Market Drivers, Challenges and Trends 10 Marketing, Distributors and Customer 11 Global In-Vitro Cancer Diagnostic Reagent Kit Market Forecast 12 Key Players Analysis 13 Research Findings and Conclusion List of TablesTable 1. In-Vitro Cancer Diagnostic Reagent Kit Consumption CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Blood Test Table 3. Major Players of Stool Test Table 4. Major Players of Urine Test Table 5. Global In-Vitro Cancer Diagnostic Reagent Kit Sales by Type (2016-2021) & (K Units) Table 6. Global In-Vitro Cancer Diagnostic Reagent Kit Sales Market Share by Type (2016-2021) Table 7. Global In-Vitro Cancer Diagnostic Reagent Kit Revenue by Type (2016-2021) & ($ million) Table 8. Global In-Vitro Cancer Diagnostic Reagent Kit Revenue Market Share by Type (2016-2021) Table 9. Global In-Vitro Cancer Diagnostic Reagent Kit Sale Price by Type (2016-2021) Table 10. Global In-Vitro Cancer Diagnostic Reagent Kit Sales by Application (2016-2021) & (K Units) Table 11. Global In-Vitro Cancer Diagnostic Reagent Kit Sales Market Share by Application (2016-2021) Table 12. Global In-Vitro Cancer Diagnostic Reagent Kit Value by Application (2016-2021) Table 13. Global In-Vitro Cancer Diagnostic Reagent Kit Revenue Market Share by Application (2016-2021) Table 14. Global In-Vitro Cancer Diagnostic Reagent Kit Sale Price by Application (2016-2021) Table 15. Global In-Vitro Cancer Diagnostic Reagent Kit Sales by Company (2019-2021) & (K Units) Table 16. Global In-Vitro Cancer Diagnostic Reagent Kit Sales Market Share by Company (2019-2021) Table 17. Global In-Vitro Cancer Diagnostic Reagent Kit Revenue by Company (2019-2021) ($ Millions) Table 18. Global In-Vitro Cancer Diagnostic Reagent Kit Revenue Market Share by Company (2019-2021) Table 19. Global In-Vitro Cancer Diagnostic Reagent Kit Sale Price by Company (2019-2021) Table 20. Key Manufacturers In-Vitro Cancer Diagnostic Reagent Kit Producing Area Distribution and Sales Area Table 21. Players In-Vitro Cancer Diagnostic Reagent Kit Products Offered Table 22. In-Vitro Cancer Diagnostic Reagent Kit Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) Table 23. New Products and Potential Entrants Table 24. Mergers & Acquisitions, Expansion Table 25. Global In-Vitro Cancer Diagnostic Reagent Kit Sales by Region (2016-2021) (K Units) Table 26. Global In-Vitro Cancer Diagnostic Reagent Kit Sales Market Share by Region (2016-2021) Table 27. Global In-Vitro Cancer Diagnostic Reagent Kit Revenue by Region (2016-2021) & ($ Millions) Table 28. Global In-Vitro Cancer Diagnostic Reagent Kit Revenue Market Share by Region (2016-2021) Table 29. Americas In-Vitro Cancer Diagnostic Reagent Kit Sales by Country (2016-2021) & (K Units) Table 30. Americas In-Vitro Cancer Diagnostic Reagent Kit Sales Market Share by Country (2016-2021) Table 31. Americas In-Vitro Cancer Diagnostic Reagent Kit Revenue by Country (2016-2021) & ($ Millions) Table 32. Americas In-Vitro Cancer Diagnostic Reagent Kit Revenue Market Share by Country (2016-2021) Table 33. Americas In-Vitro Cancer Diagnostic Reagent Kit Sales by Type (2016-2021) & (K Units) Table 34. Americas In-Vitro Cancer Diagnostic Reagent Kit Sales Market Share by Type (2016-2021) Table 35. Americas In-Vitro Cancer Diagnostic Reagent Kit Sales by Application (2016-2021) & (K Units) Table 36. Americas In-Vitro Cancer Diagnostic Reagent Kit Sales Market Share by Application (2016-2021) Table 37. APAC In-Vitro Cancer Diagnostic Reagent Kit Sales by Region (2016-2021) & (K Units) Table 38. APAC In-Vitro Cancer Diagnostic Reagent Kit Sales Market Share by Region (2016-2021) Table 39. APAC In-Vitro Cancer Diagnostic Reagent Kit Revenue by Region (2016-2021) & ($ Millions) Table 40. APAC In-Vitro Cancer Diagnostic Reagent Kit Revenue Market Share by Region (2016-2021) Table 41. APAC In-Vitro Cancer Diagnostic Reagent Kit Sales by Type (2016-2021) & (K Units) Table 42. APAC In-Vitro Cancer Diagnostic Reagent Kit Sales Market Share by Type (2016-2021) Table 43. APAC In-Vitro Cancer Diagnostic Reagent Kit Sales by Application (2016-2021) & (K Units) Table 44. APAC In-Vitro Cancer Diagnostic Reagent Kit Sales Market Share by Application (2016-2021) Table 45. Europe In-Vitro Cancer Diagnostic Reagent Kit Sales by Country (2016-2021) & (K Units) Table 46. Europe In-Vitro Cancer Diagnostic Reagent Kit Sales Market Share by Country (2016-2021) Table 47. Europe In-Vitro Cancer Diagnostic Reagent Kit Revenue by Country (2016-2021) & ($ Millions) Table 48. Europe In-Vitro Cancer Diagnostic Reagent Kit Revenue Market Share by Country (2016-2021) Table 49. Europe In-Vitro Cancer Diagnostic Reagent Kit Sales by Type (2016-2021) & (K Units) Table 50. Europe In-Vitro Cancer Diagnostic Reagent Kit Sales Market Share by Type (2016-2021) Table 51. Europe In-Vitro Cancer Diagnostic Reagent Kit Sales by Application (2016-2021) & (K Units) Table 52. Europe In-Vitro Cancer Diagnostic Reagent Kit Sales Market Share by Application (2016-2021) Table 53. Middle East & Africa In-Vitro Cancer Diagnostic Reagent Kit Sales by Country (2016-2021) & (K Units) Table 54. Middle East & Africa In-Vitro Cancer Diagnostic Reagent Kit Sales Market Share by Country (2016-2021) Table 55. Middle East & Africa In-Vitro Cancer Diagnostic Reagent Kit Revenue by Country (2016-2021) & ($ Millions) Table 56. Middle East & Africa In-Vitro Cancer Diagnostic Reagent Kit Revenue Market Share by Country (2016-2021) Table 57. Middle East & Africa In-Vitro Cancer Diagnostic Reagent Kit Sales by Type (2016-2021) & (K Units) Table 58. Middle East & Africa In-Vitro Cancer Diagnostic Reagent Kit Sales Market Share by Type (2016-2021) Table 59. Middle East & Africa In-Vitro Cancer Diagnostic Reagent Kit Sales by Application (2016-2021) & (K Units) Table 60. Middle East & Africa In-Vitro Cancer Diagnostic Reagent Kit Sales Market Share by Application (2016-2021) Table 61. Key and Potential Regions of In-Vitro Cancer Diagnostic Reagent Kit Table 62. Key Application and Potential Industries of In-Vitro Cancer Diagnostic Reagent Kit Table 63. Key Challenges of In-Vitro Cancer Diagnostic Reagent Kit Table 64. Key Trends of In-Vitro Cancer Diagnostic Reagent Kit Table 65. In-Vitro Cancer Diagnostic Reagent Kit Distributors List Table 66. In-Vitro Cancer Diagnostic Reagent Kit Customer List Table 67. Global In-Vitro Cancer Diagnostic Reagent Kit Sales Forecast by Region (2021-2026) & (K Units) Table 68. Global In-Vitro Cancer Diagnostic Reagent Kit Consumption Market Forecast by Region Table 69. Global In-Vitro Cancer Diagnostic Reagent Kit Revenue Forecast by Region (2021-2026) & ($ millions) Table 70. Global In-Vitro Cancer Diagnostic Reagent Kit Revenue Market Share Forecast by Region (2021-2026) Table 71. Americas In-Vitro Cancer Diagnostic Reagent Kit Sales Forecast by Country (2021-2026) & (K Units) Table 72. Americas In-Vitro Cancer Diagnostic Reagent Kit Revenue Forecast by Country (2021-2026) & ($ millions) Table 73. APAC In-Vitro Cancer Diagnostic Reagent Kit Sales Forecast by Region (2021-2026) & (K Units) Table 74. APAC In-Vitro Cancer Diagnostic Reagent Kit Revenue Forecast by Region (2021-2026) & ($ millions) Table 75. Europe In-Vitro Cancer Diagnostic Reagent Kit Sales Forecast by Country (2021-2026) & (K Units) Table 76. Europe In-Vitro Cancer Diagnostic Reagent Kit Revenue Forecast by Country (2021-2026) & ($ millions) Table 77. Middle East & Africa In-Vitro Cancer Diagnostic Reagent Kit Sales Forecast by Country (2021-2026) & (K Units) Table 78. Middle East & Africa In-Vitro Cancer Diagnostic Reagent Kit Revenue Forecast by Country (2021-2026) & ($ millions) Table 79. Global In-Vitro Cancer Diagnostic Reagent Kit Sales Forecast by Type (2021-2026) & (K Units) Table 80. Global In-Vitro Cancer Diagnostic Reagent Kit Sales Market Share Forecast by Type (2021-2026) Table 81. Global In-Vitro Cancer Diagnostic Reagent Kit Revenue Forecast by Type (2021-2026) & ($ Millions) Table 82. Global In-Vitro Cancer Diagnostic Reagent Kit Revenue Market Share Forecast by Type (2021-2026) Table 83. Global In-Vitro Cancer Diagnostic Reagent Kit Sales Forecast by Application (2021-2026) & (K Units) Table 84. Global In-Vitro Cancer Diagnostic Reagent Kit Sales Market Share Forecast by Application (2021-2026) Table 85. Global In-Vitro Cancer Diagnostic Reagent Kit Revenue Forecast by Application (2021-2026) & ($ Millions) Table 86. Global In-Vitro Cancer Diagnostic Reagent Kit Revenue Market Share Forecast by Application (2021-2026) Table 87. Abbott Basic Information, In-Vitro Cancer Diagnostic Reagent Kit Manufacturing Base, Sales Area and Its Competitors Table 88. Abbott In-Vitro Cancer Diagnostic Reagent Kit Product Offered Table 89. Abbott In-Vitro Cancer Diagnostic Reagent Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 90. Abbott Main Business Table 91. Abbott Latest Developments Table 92. Beckman Coulter Basic Information, In-Vitro Cancer Diagnostic Reagent Kit Manufacturing Base, Sales Area and Its Competitors Table 93. Beckman Coulter In-Vitro Cancer Diagnostic Reagent Kit Product Offered Table 94. Beckman Coulter In-Vitro Cancer Diagnostic Reagent Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 95. Beckman Coulter Main Business Table 96. Beckman Coulter Latest Developments Table 97. Siemens Healthcare Basic Information, In-Vitro Cancer Diagnostic Reagent Kit Manufacturing Base, Sales Area and Its Competitors Table 98. Siemens Healthcare In-Vitro Cancer Diagnostic Reagent Kit Product Offered Table 99. Siemens Healthcare In-Vitro Cancer Diagnostic Reagent Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 100. Siemens Healthcare Main Business Table 101. Siemens Healthcare Latest Developments Table 102. Eiken Chemical Basic Information, In-Vitro Cancer Diagnostic Reagent Kit Manufacturing Base, Sales Area and Its Competitors Table 103. Eiken Chemical In-Vitro Cancer Diagnostic Reagent Kit Product Offered Table 104. Eiken Chemical In-Vitro Cancer Diagnostic Reagent Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 105. Eiken Chemical Main Business Table 106. Eiken Chemical Latest Developments Table 107. Hitachi Chemical Diagnostics Systems Basic Information, In-Vitro Cancer Diagnostic Reagent Kit Manufacturing Base, Sales Area and Its Competitors Table 108. Hitachi Chemical Diagnostics Systems In-Vitro Cancer Diagnostic Reagent Kit Product Offered Table 109. Hitachi Chemical Diagnostics Systems In-Vitro Cancer Diagnostic Reagent Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 110. Hitachi Chemical Diagnostics Systems Main Business Table 111. Hitachi Chemical Diagnostics Systems Latest Developments Table 112. Clinical Genomics Pty Ltd (Quest Diagnostics) Basic Information, In-Vitro Cancer Diagnostic Reagent Kit Manufacturing Base, Sales Area and Its Competitors Table 113. Clinical Genomics Pty Ltd (Quest Diagnostics) In-Vitro Cancer Diagnostic Reagent Kit Product Offered Table 114. Clinical Genomics Pty Ltd (Quest Diagnostics) In-Vitro Cancer Diagnostic Reagent Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 115. Clinical Genomics Pty Ltd (Quest Diagnostics) Main Business Table 116. Clinical Genomics Pty Ltd (Quest Diagnostics) Latest Developments Table 117. Sysmex Basic Information, In-Vitro Cancer Diagnostic Reagent Kit Manufacturing Base, Sales Area and Its Competitors Table 118. Sysmex In-Vitro Cancer Diagnostic Reagent Kit Product Offered Table 119. Sysmex In-Vitro Cancer Diagnostic Reagent Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 120. Sysmex Main Business Table 121. Sysmex Latest Developments Table 122. QIAGEN Basic Information, In-Vitro Cancer Diagnostic Reagent Kit Manufacturing Base, Sales Area and Its Competitors Table 123. QIAGEN In-Vitro Cancer Diagnostic Reagent Kit Product Offered Table 124. QIAGEN In-Vitro Cancer Diagnostic Reagent Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 125. QIAGEN Main Business Table 126. QIAGEN Latest Developments Table 127. R-Biopharm Basic Information, In-Vitro Cancer Diagnostic Reagent Kit Manufacturing Base, Sales Area and Its Competitors Table 128. R-Biopharm In-Vitro Cancer Diagnostic Reagent Kit Product Offered Table 129. R-Biopharm In-Vitro Cancer Diagnostic Reagent Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 130. R-Biopharm Main Business Table 131. R-Biopharm Latest Developments Table 132. Immunostics Basic Information, In-Vitro Cancer Diagnostic Reagent Kit Manufacturing Base, Sales Area and Its Competitors Table 133. Immunostics In-Vitro Cancer Diagnostic Reagent Kit Product Offered Table 134. Immunostics In-Vitro Cancer Diagnostic Reagent Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 135. Immunostics Main Business Table 136. Immunostics Latest Developments Table 137. OPKO Basic Information, In-Vitro Cancer Diagnostic Reagent Kit Manufacturing Base, Sales Area and Its Competitors Table 138. OPKO In-Vitro Cancer Diagnostic Reagent Kit Product Offered Table 139. OPKO In-Vitro Cancer Diagnostic Reagent Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 140. OPKO Main Business Table 141. OPKO Latest Developments Table 142. Epigenomics AG Basic Information, In-Vitro Cancer Diagnostic Reagent Kit Manufacturing Base, Sales Area and Its Competitors Table 143. Epigenomics AG In-Vitro Cancer Diagnostic Reagent Kit Product Offered Table 144. Epigenomics AG In-Vitro Cancer Diagnostic Reagent Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 145. Epigenomics AG Main Business Table 146. Epigenomics AG Latest Developments Table 147. bioMeriux Basic Information, In-Vitro Cancer Diagnostic Reagent Kit Manufacturing Base, Sales Area and Its Competitors Table 148. bioMeriux In-Vitro Cancer Diagnostic Reagent Kit Product Offered Table 149. bioMeriux In-Vitro Cancer Diagnostic Reagent Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 150. bioMeriux Main Business Table 151. bioMeriux Latest Developments Table 152. Roche Basic Information, In-Vitro Cancer Diagnostic Reagent Kit Manufacturing Base, Sales Area and Its Competitors Table 153. Roche In-Vitro Cancer Diagnostic Reagent Kit Product Offered Table 154. Roche In-Vitro Cancer Diagnostic Reagent Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 155. Roche Main Business Table 156. Roche Latest Developments Table 157. MDx Health Basic Information, In-Vitro Cancer Diagnostic Reagent Kit Manufacturing Base, Sales Area and Its Competitors Table 158. MDx Health In-Vitro Cancer Diagnostic Reagent Kit Product Offered Table 159. MDx Health In-Vitro Cancer Diagnostic Reagent Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 160. MDx Health Main Business Table 161. MDx Health Latest Developments Table 162. Randox Laboratories Basic Information, In-Vitro Cancer Diagnostic Reagent Kit Manufacturing Base, Sales Area and Its Competitors Table 163. Randox Laboratories In-Vitro Cancer Diagnostic Reagent Kit Product Offered Table 164. Randox Laboratories In-Vitro Cancer Diagnostic Reagent Kit Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 165. Randox Laboratories Main Business Table 166. Randox Laboratories Latest Developments List of Figures Figure 1. Picture of In-Vitro Cancer Diagnostic Reagent Kit Figure 2. In-Vitro Cancer Diagnostic Reagent Kit Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global In-Vitro Cancer Diagnostic Reagent Kit Sales Growth Rate 2016-2026 (K Units) Figure 7. Global In-Vitro Cancer Diagnostic Reagent Kit Revenue Growth Rate 2016-2026 ($ Millions) Figure 8. In-Vitro Cancer Diagnostic Reagent Kit Sales by Region (2021 & 2026) & ($ millions) Figure 9. Product Picture of Blood Test Figure 10. Product Picture of Stool Test Figure 11. Product Picture of Urine Test Figure 12. Global In-Vitro Cancer Diagnostic Reagent Kit Sales Market Share by Type in 2020 Figure 13. Global In-Vitro Cancer Diagnostic Reagent Kit Revenue Market Share by Type (2016-2021) Figure 14. In-Vitro Cancer Diagnostic Reagent Kit Consumed in Lung Cancer Figure 15. Global In-Vitro Cancer Diagnostic Reagent Kit Market: Lung Cancer (2016-2021) & (K Units) Figure 16. In-Vitro Cancer Diagnostic Reagent Kit Consumed in Colorectal Cancer Figure 17. Global In-Vitro Cancer Diagnostic Reagent Kit Market: Colorectal Cancer (2016-2021) & (K Units) Figure 18. In-Vitro Cancer Diagnostic Reagent Kit Consumed in Prostate Cancer Figure 19. Global In-Vitro Cancer Diagnostic Reagent Kit Market: Prostate Cancer (2016-2021) & (K Units) Figure 20. In-Vitro Cancer Diagnostic Reagent Kit Consumed in Breast Cancer Figure 21. Global In-Vitro Cancer Diagnostic Reagent Kit Market: Breast Cancer (2016-2021) & (K Units) Figure 22. In-Vitro Cancer Diagnostic Reagent Kit Consumed in Ovarian Cancer Figure 23. Global In-Vitro Cancer Diagnostic Reagent Kit Market: Ovarian Cancer (2016-2021) & (K Units) Figure 24. In-Vitro Cancer Diagnostic Reagent Kit Consumed in Other Figure 25. Global In-Vitro Cancer Diagnostic Reagent Kit Market: Other (2016-2021) & (K Units) Figure 26. Global In-Vitro Cancer Diagnostic Reagent Kit Sales Market Share by Application (2016-2021) Figure 27. Global In-Vitro Cancer Diagnostic Reagent Kit Revenue Market Share by Application in 2020 Figure 28. In-Vitro Cancer Diagnostic Reagent Kit Revenue Market by Company in 2020 ($ Million) Figure 29. Global In-Vitro Cancer Diagnostic Reagent Kit Revenue Market Share by Company in 2020 Figure 30. Global In-Vitro Cancer Diagnostic Reagent Kit Sales Market Share by Regions (2016-2021) Figure 31. Global In-Vitro Cancer Diagnostic Reagent Kit Revenue Market Share by Region in 2020 Figure 32. Americas In-Vitro Cancer Diagnostic Reagent Kit Sales 2016-2021 (K Units) Figure 33. Americas In-Vitro Cancer Diagnostic Reagent Kit Revenue 2016-2021 ($ Millions) Figure 34. APAC In-Vitro Cancer Diagnostic Reagent Kit Sales 2016-2021 (K Units) Figure 35. APAC In-Vitro Cancer Diagnostic Reagent Kit Revenue 2016-2021 ($ Millions) Figure 36. Europe In-Vitro Cancer Diagnostic Reagent Kit Sales 2016-2021 (K Units) Figure 37. Europe In-Vitro Cancer Diagnostic Reagent Kit Revenue 2016-2021 ($ Millions) Figure 38. Middle East & Africa In-Vitro Cancer Diagnostic Reagent Kit Sales 2016-2021 (K Units) Figure 39. Middle East & Africa In-Vitro Cancer Diagnostic Reagent Kit Revenue 2016-2021 ($ Millions) Figure 40. Americas In-Vitro Cancer Diagnostic Reagent Kit Sales Market Share by Country in 2020 Figure 41. Americas In-Vitro Cancer Diagnostic Reagent Kit Revenue Market Share by Country in 2020 Figure 42. Americas In-Vitro Cancer Diagnostic Reagent Kit Sales Market Share by Type in 2020 Figure 43. Americas In-Vitro Cancer Diagnostic Reagent Kit Sales Market Share by Application in 2020 Figure 44. United States In-Vitro Cancer Diagnostic Reagent Kit Revenue Growth 2016-2021 ($ Millions) Figure 45. Canada In-Vitro Cancer Diagnostic Reagent Kit Revenue Growth 2016-2021 ($ Millions) Figure 46. Mexico In-Vitro Cancer Diagnostic Reagent Kit Revenue Growth 2016-2021 ($ Millions) Figure 47. Brazil In-Vitro Cancer Diagnostic Reagent Kit Revenue Growth 2016-2021 ($ Millions) Figure 48. APAC In-Vitro Cancer Diagnostic Reagent Kit Sales Market Share by Region in 2020 Figure 49. APAC In-Vitro Cancer Diagnostic Reagent Kit Revenue Market Share by Regions in 2020 Figure 50. APAC In-Vitro Cancer Diagnostic Reagent Kit Sales Market Share by Type in 2020 Figure 51. APAC In-Vitro Cancer Diagnostic Reagent Kit Sales Market Share by Application in 2020 Figure 52. China In-Vitro Cancer Diagnostic Reagent Kit Revenue Growth 2016-2021 ($ Millions) Figure 53. Japan In-Vitro Cancer Diagnostic Reagent Kit Revenue Growth 2016-2021 ($ Millions) Figure 54. Korea In-Vitro Cancer Diagnostic Reagent Kit Revenue Growth 2016-2021 ($ Millions) Figure 55. Southeast Asia In-Vitro Cancer Diagnostic Reagent Kit Revenue Growth 2016-2021 ($ Millions) Figure 56. India In-Vitro Cancer Diagnostic Reagent Kit Revenue Growth 2016-2021 ($ Millions) Figure 57. Australia In-Vitro Cancer Diagnostic Reagent Kit Revenue Growth 2016-2021 ($ Millions) Figure 58. Europe In-Vitro Cancer Diagnostic Reagent Kit Sales Market Share by Country in 2020 Figure 59. Europe In-Vitro Cancer Diagnostic Reagent Kit Revenue Market Share by Country in 2020 Figure 60. Europe In-Vitro Cancer Diagnostic Reagent Kit Sales Market Share by Type in 2020 Figure 61. Europe In-Vitro Cancer Diagnostic Reagent Kit Sales Market Share by Application in 2020 Figure 62. Germany In-Vitro Cancer Diagnostic Reagent Kit Revenue Growth 2016-2021 ($ Millions) Figure 63. France In-Vitro Cancer Diagnostic Reagent Kit Revenue Growth 2016-2021 ($ Millions) Figure 64. UK In-Vitro Cancer Diagnostic Reagent Kit Revenue Growth 2016-2021 ($ Millions) Figure 65. Italy In-Vitro Cancer Diagnostic Reagent Kit Revenue Growth 2016-2021 ($ Millions) Figure 66. Russia In-Vitro Cancer Diagnostic Reagent Kit Revenue Growth 2016-2021 ($ Millions) Figure 67. Middle East & Africa In-Vitro Cancer Diagnostic Reagent Kit Sales Market Share by Country in 2020 Figure 68. Middle East & Africa In-Vitro Cancer Diagnostic Reagent Kit Revenue Market Share by Country in 2020 Figure 69. Middle East & Africa In-Vitro Cancer Diagnostic Reagent Kit Sales Market Share by Type in 2020 Figure 70. Middle East & Africa In-Vitro Cancer Diagnostic Reagent Kit Sales Market Share by Application in 2020 Figure 71. Egypt In-Vitro Cancer Diagnostic Reagent Kit Revenue Growth 2016-2021 ($ Millions) Figure 72. South Africa In-Vitro Cancer Diagnostic Reagent Kit Revenue Growth 2016-2021 ($ Millions) Figure 73. Israel In-Vitro Cancer Diagnostic Reagent Kit Revenue Growth 2016-2021 ($ Millions) Figure 74. Turkey In-Vitro Cancer Diagnostic Reagent Kit Revenue Growth 2016-2021 ($ Millions) Figure 75. GCC Country In-Vitro Cancer Diagnostic Reagent Kit Revenue Growth 2016-2021 ($ Millions) Figure 76. Channels of Distribution Figure 77. Distributors Profiles |
| ※본 조사보고서 [세계의 체외 암 진단 시약 키트 시장예측 2021년-2026년] (코드 : LPI-2201K00305) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 체외 암 진단 시약 키트 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요. |